The cardiovascular system and adrenergic inhibition
Arkatov, V.A.; Korotkoruchko, A.A.
Anesteziologiia i Reanimatologiia 5: 70-74
1986
ISSN/ISBN: 0201-7563 PMID: 2880533 Document Number: 278489
Document emailed within 1 workday
Related Documents
Haber, E. 1983: Immunologic approaches to the inhibition of renin and the adrenergic system Federation Proceedings 42(10): 2661-2666Paleev, N.R.; Kaevitser, I.M.; Kublanov, L.A. 1977: Determination of the individual changes in cardiovascular system reactivity in prescribing adrenergic blockaders Kardiologiia 17(11): 103-108
Takenaka, F.; Ishihara, T.; Maruyama, Y.; Matsumoto, S.; Inoue, H. 1974: Effects of an adrenergic beta-receptor blockader, 2-acetyl-7-(2-hydroxy-3-isopropylamino) propoxybenzofuran hydrochloride on the cardiovascular system Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 70(3): 385-397
Ariëns, E.J. 1970: Pharmacology of the adrenergic system. II. Drug interference with the storage of catecholamines in and the release of catecholamines from the adrenergic system Pharmaceutisch Weekblad 105(33): 885-895
Jabloński, J. 1974: Sympathetic (adrenergic) nervous system and its importance in the physiology and pathology of the eye. I. Contemporary views on processes taking place in peripheral adrenergic tissues Klinika Oczna 44(3): 281-286
Bruynzeel, P.L. 1984: Changes in the beta-adrenergic system due to beta-adrenergic therapy: clinical consequences European Journal of Respiratory Diseases. Supplement 135: 62-71
Makar, O.; Siabrenko, G. 2018: Influence of Physical Activity on Cardiovascular System and Prevention of Cardiovascular Diseases (Review) Georgian Medical News 2018(285): 69-74
Kostyukevich, M.V.; Zykov, K.A.; Mironova, N.A.; Agapova, O.Y.; Shevelev, A.Y.; Efremov, E.E.; Vlasik, T.N.; Golitsyn, S.P. 2016: Role of Autoantibodies Against 1-Adrenergic Receptor in Cardiovascular Disease Kardiologiia 56(12): 82-91
Davis, M.S.; Shuttleworth, T.J. 1986: Mode of adrenergic and peptidergic inhibition of ion transport in flounder gill American Journal of Physiology 251(6 Pt 2): R1064-R1070
Gorczynski, R.J.; Reynolds, R.D. 1985: Cardiovascular pharmacology of ASL-7022. III. Peripheral vascular adrenergic mechanisms Journal of Pharmacology and Experimental Therapeutics 232(3): 629-635
Yoshida, T.; Takano, M.; Tamura, A.; Kubota, H.; Suzuki, N. 1970: Cardiovascular effects and antiarrhythmic action of a new beta adrenergic blocker, LB-46 Masui. Japanese Journal of Anesthesiology 19(5): 515-522
Privitera, P.J.; Blickenstaff, T.; Gaffney, T.E.; Mohammed, S. 1971: Adrenergic blocking and cardiovascular effects of a new N-substituted tetrahydroisoquinoline (NC 7197) Journal of Pharmacology and Experimental Therapeutics 176(3): 655-661
Ribeiro, C.P.; Ribeiro-Neto, F.; Field, J.B.; Suki, W.N. 1987: Prevention of alpha 2-adrenergic inhibition on ADH action by pertussis toxin in rabbit CCT American Journal of Physiology 253(1 Pt 1): C105-C112
Andersson, K.E.; Ingemarsson, I. 1975: Inhibition of uterine activity by means of adrenergic beta receptor stimulators Lakartidningen 72(3): 138-141
Vallès Prats, M.; Matas Serra, M.; Bronsoms Artero, J.; Matè Benito, G.; Torguet Escuder, P.; Mauri Nicolas, J.M. 1996: Quinapril ACE-inhibition effects on adrenergic parameters in moderate essential hypertension Kidney International. Supplement 55: S104-S106
Janssens, W.J.; Verhaeghe, R.H. 1980: Inhibition of adrenergic neurotransmission in canine saphenous veins and tibial arteries by streptokinase Archives Internationales de Pharmacodynamie et de Therapie 246(1): 175-176
Tarasenko, L.M.; Deviatkina, T.A.; Tsebrzhinskiĭ, O.I.; Grebennikova, V.F.; Klusha, V.E. 1991: The adrenergic mechanisms of the inhibition of the gastric acid-forming function in acute stress Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 3: 47-48
Ratner, A.; Weiss, G.K.; Sanborn, C.R. 1983: Alpha adrenergic mediated inhibition of progesterone and cyclic AMP production in rat ovarian tissue Proceedings of the Western Pharmacology Society 26: 25-29
Hoffmann, P.; Müller, S. 1990: Subacute carbon disulfide exposure modifies adrenergic cardiovascular actions in rats Biomedica Biochimica Acta 49(1): 115-120
Bousquet, P.; Feldman, J.; Schwartz, J. 1984: Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines Journal of Pharmacology and Experimental Therapeutics 230(1): 232-236